These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 31060996)
1. Serum miR-551b-3p is a potential diagnostic biomarker for gastric cancer. Bai SY; Ji R; Wei H; Guo QH; Yuan H; Chen ZF; Wang YP; Liu Z; Yang XY; Zhou YN Turk J Gastroenterol; 2019 May; 30(5):415-419. PubMed ID: 31060996 [TBL] [Abstract][Full Text] [Related]
2. Identification of diagnostic utility and molecular mechanisms of circulating miR-551b-5p in gastric cancer. Jiang X; Jiang M; Xu M; Xu J; Li Y Pathol Res Pract; 2019 May; 215(5):900-904. PubMed ID: 30732916 [TBL] [Abstract][Full Text] [Related]
3. Expression Levels of miR-127-3p and miR-144-3p in Gastric Cancer and their Relationships with Clinicopathological Parameters. Sahami-Fard MH; Yazd EF; Jamalpoor Z; Nezhadi A Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538067 [TBL] [Abstract][Full Text] [Related]
4. Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma. Han X; Li X; Zhao H; Zhou D; Sun B; Liu A; Zhang J; Cui Z; Ma X; Yuan L J Cell Biochem; 2019 Sep; 120(9):15834-15843. PubMed ID: 31081157 [TBL] [Abstract][Full Text] [Related]
5. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer. An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Potential of Janiczek-Polewska M; Kolenda T; Poter P; Kozłowska-Masłoń J; Jagiełło I; Regulska K; Malicki J; Marszałek A Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125625 [TBL] [Abstract][Full Text] [Related]
7. Circulating serum exosomal Lu X; Lu J; Wang S; Zhang Y; Ding Y; Shen X; Jing R; Ju S; Chen H; Cong H Future Oncol; 2021 Mar; 17(8):907-919. PubMed ID: 33533649 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer. Kong Y; Ning L; Qiu F; Yu Q; Cao B Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187 [TBL] [Abstract][Full Text] [Related]
9. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
10. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer]. Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770 [No Abstract] [Full Text] [Related]
11. Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer. Guo Y; Cui X; Zhang Y; Ma X; Ren A; Huang H Cancer Biother Radiopharm; 2023 Mar; 38(2):95-101. PubMed ID: 32898433 [No Abstract] [Full Text] [Related]
12. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250 [TBL] [Abstract][Full Text] [Related]
13. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer. Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338 [TBL] [Abstract][Full Text] [Related]
14. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer. Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551 [TBL] [Abstract][Full Text] [Related]
15. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Cai H; Yuan Y; Hao YF; Guo TK; Wei X; Zhang YM Med Oncol; 2013 Mar; 30(1):452. PubMed ID: 23307259 [TBL] [Abstract][Full Text] [Related]
16. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. Valladares-Ayerbes M; Reboredo M; Medina-Villaamil V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Haz M; Santamarina I; Blanco M; Fernández-Tajes J; Quindós M; Carral A; Figueroa A; Antón-Aparicio LM; Calvo L J Transl Med; 2012 Sep; 10():186. PubMed ID: 22954417 [TBL] [Abstract][Full Text] [Related]
17. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients. Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer. Yuan H; Chen Z; Bai S; Wei H; Wang Y; Ji R; Guo Q; Li Q; Ye Y; Wu J; Zhou Y; Qiao L Cancer Lett; 2018 Apr; 418():84-96. PubMed ID: 29337109 [TBL] [Abstract][Full Text] [Related]
19. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer. Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167 [TBL] [Abstract][Full Text] [Related]
20. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer. Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]